Egis in the World

Our products are available in 62 countries

Click here to learn more

Pharma Company

Our activities incorporate all areas of the pharmaceutical value chain

Click here to learn more

Research & Development

Innovation is one of the pillars of our strategy. We devote more than EUR 45 million to research and development.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners
Corporate Social Responsibility

«EGIS-RUS» obtained the certificate for compliance with the requirements of international ISO standards

EMS (Environmental Management System) of EGIS-RUS successfully passed a certification audit for compliance with ISO 14001:2015 requirements. The audit was conducted by the International Organization for Standardization and Certification Bureau Veritas (Bureau Veritas Certification Rus JSC). Meeting the requirements of the ISO standards confirms the commitment of the management and employees to the highest requirements for climate protection and reduction of their environmental impact.


The first and only fixed-dose combination of atorvastatin and esetimibe in Russia

Egis launches in Russia a product with fixed-doses of atorvastatin and ezetimibe in one capsule for the treatment of hypercholesterolemia [1]. Fixed-dose combination (FDC) developed by Egis will increase adherence in patients who take atorvastatin and ezetimibe separately, and a single dose per day should significantly simplify the drug therapy regimen.

Our People

Celebrating our company’s 110th anniversary

The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.

More articles

Egis in the World

Egis is present in 62 countries with its products.

Egis’ products are available in 62 countries. Our portfolio consists of 642 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

Place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. The information in this section is for healthcare specialists only!

Learn more
Therapic areas
Therapic areas
Cardiovascular system
Central nervous system
Women´s health

Principles of Pharmacovigilance

Please report any adverse events

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox